UK: A secondary analysis of the FINEARTS-HF randomized clinical trial evaluated the performance of the PREDICT-HFpEF model in ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection fraction, and heart failure with reduced ejection fraction.

in the EMPEROR-Preserved in July 2021 in heart failure preserved ejection fraction (HFpEF). Farxiga – known as Forxiga in some markets – has been beating a trail for the SLGT2 inhibitor class ...

Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker ...

Amendment to Enlarge Phase 3 LEVEL Study, Increasing Statistical Powering, Accepted by FDA, Expected to be Fully Enrolled Around Year End ...

We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...

Tenax Therapeutics said it extended Phase 3 clinical development of PH treatment TNX-103, an oral form of levosimendan.